Sunday, August 14, 2016 7:28:51 PM
I see it differently: PMCB is down 93.04% from 2/27/2014 (.51) I know KW was appointed on 9/17/2014 but it is now currently at an all time low, a 52 week change of -58.20%
uncertainly of funding, all the delays, FDA approval unknown at this point, and unknown results of a clinical trail, if it happens.
1) PMCB uncertain to raise cash
2) PMCB unknown if PMCB submitted a Pre Ind request
3) PMCB stock is selling very close to an all time low
4) PMCB has a poor balance sheet-no stockholders equity
5) PMCB has 1 minor fund (maybe) and no outside Pharma holding shares
6) PMCB clinical trial may be pushed into 2017
7) PMCB has 20yr old technology-
8) PMCB O/S increases 8.6% last 10k,has less assets that the last financials-
9) PMCB- taking an extremly long time to go to trials
uncertainly of funding, all the delays, FDA approval unknown at this point, and unknown results of a clinical trail, if it happens.
1) PMCB uncertain to raise cash
2) PMCB unknown if PMCB submitted a Pre Ind request
3) PMCB stock is selling very close to an all time low
4) PMCB has a poor balance sheet-no stockholders equity
5) PMCB has 1 minor fund (maybe) and no outside Pharma holding shares
6) PMCB clinical trial may be pushed into 2017
7) PMCB has 20yr old technology-
8) PMCB O/S increases 8.6% last 10k,has less assets that the last financials-
9) PMCB- taking an extremly long time to go to trials
Recent PMCB News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:16:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 08:19:59 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/17/2026 07:49:54 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/09/2026 01:40:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/09/2026 10:02:46 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/27/2026 10:05:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2026 10:43:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2026 10:43:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/18/2025 10:04:23 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 12/15/2025 09:00:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2025 10:07:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2025 10:00:25 PM
- PharmaCyte Biotech stock surges following profitable exit from Femasys investment • IH Market News • 11/25/2025 03:56:47 PM
- PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment • Business Wire • 11/25/2025 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/18/2025 09:32:29 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/18/2025 09:05:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 08:05:33 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/06/2025 09:08:43 PM
